Acutaas Chemicals Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹3619.40
Market cap
29,635 Cr
Stock P/E
83.2
P/B
17.32
Dividend yield
0.0%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales142 Cr172 Cr166 Cr225 Cr177 Cr247 Cr275 Cr308 Cr207 Cr306 Cr393 Cr433 Cr
Operating expenses (approx.)117 Cr179 Cr140 Cr181 Cr147 Cr198 Cr206 Cr218 Cr156 Cr211 Cr243 Cr238 Cr
EBITDA25 Cr-7 Cr27 Cr44 Cr30 Cr49 Cr69 Cr91 Cr51 Cr95 Cr151 Cr195 Cr
OPM %17.7%-4.0%15.9%19.6%16.7%19.8%25.0%29.4%24.6%31.1%38.3%45.0%
Other income1 Cr2 Cr3 Cr1 Cr1 Cr8 Cr2 Cr6 Cr16 Cr10 Cr5 Cr11 Cr
Interest0.51 Cr0.82 Cr3 Cr2 Cr4 Cr0.50 Cr0.69 Cr0.60 Cr0.64 Cr0.58 Cr0.86 Cr1 Cr
Depreciation3 Cr4 Cr4 Cr5 Cr6 Cr7 Cr6 Cr7 Cr8 Cr8 Cr10 Cr10 Cr
Profit before tax22 Cr-10 Cr24 Cr37 Cr20 Cr50 Cr63 Cr83 Cr58 Cr96 Cr145 Cr184 Cr
Tax %25.4%-71.2%24.9%31.0%26.4%24.9%28.2%24.3%24.2%25.3%26.6%26.9%
Net profit17 Cr-17 Cr18 Cr26 Cr15 Cr38 Cr45 Cr63 Cr44 Cr72 Cr106 Cr134 Cr
EPS (₹)₹4.57₹-4.67₹4.83₹6.86₹3.67₹9.38₹11.35₹7.80₹5.41₹8.82₹13.19₹16.09

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales520 Cr617 Cr717 Cr1,007 Cr1,339 CrSign in for TTM
Operating expenses (approx.)412 Cr494 Cr621 Cr758 Cr817 CrSign in for TTM
EBITDA108 Cr123 Cr96 Cr249 Cr522 CrSign in for TTM
OPM %20.8%19.9%13.4%24.7%39.0%Sign in for TTM
Other income3 Cr4 Cr7 Cr17 Cr42 CrSign in for TTM
Interest6 Cr2 Cr6 Cr6 Cr3 CrSign in for TTM
Depreciation10 Cr12 Cr16 Cr27 Cr36 CrSign in for TTM
Profit before tax91 Cr112 Cr82 Cr216 Cr483 CrSign in for TTM
Tax %21.3%25.7%40.5%25.8%26.2%Sign in for TTM
Net profit72 Cr83 Cr49 Cr160 Cr356 CrSign in for TTM
EPS (₹)₹21.03₹22.86₹11.67₹19.81₹43.51Sign in for TTM
Dividend payout %0.0%13.1%22.4%7.7%3.4%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital36 Cr36 Cr37 Cr41 Cr41 Cr
Reserves486 Cr558 Cr637 Cr1,269 Cr1,613 Cr
Borrowings—4 Cr217 Cr8 Cr26 Cr
Other liabilities—169 Cr196 Cr221 Cr247 Cr
Total liabilities—767 Cr1,096 Cr1,549 Cr1,984 Cr
Fixed assets (net)—222 Cr360 Cr505 Cr633 Cr
CWIP—26 Cr125 Cr130 Cr332 Cr
Investments—2 Cr0.20 Cr0.20 Cr0.20 Cr
Other assets—471 Cr497 Cr794 Cr884 Cr
Total assets—767 Cr1,096 Cr1,549 Cr1,984 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity-9 Cr66 Cr125 Cr118 Cr292 Cr
Cash from investing-124 Cr-33 Cr-365 Cr-224 Cr-266 Cr
Cash from financing140 Cr-12 Cr239 Cr261 Cr4 Cr
Net cash flow8 Cr20 Cr-0.86 Cr156 Cr30 Cr
Free cash flow (OCF − Capex)-9 Cr-31 Cr-155 Cr-76 Cr-36 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %18.7%18.5%8.9%16.7%28.0%
ROE %13.8%0.0%6.3%12.0%20.8%
Debtor days—136105——
Inventory days—125130115142
Days payable—150112——
Cash conversion cycle—112123115142
Debt / equity—0.00610.320.00620.02
Current ratio—2.891.743.913.82
Net debt / EBITDA0.00-0.221.94-0.71-0.36

Compare with peers

Loading peers…